Marijuana - Public Weed Stocks & Analysis

[DollarsOnPennies]

$CNBX Weekly - Cannabics Pharmaceuticals, Inc. is an emerging drug development company focused on the development and commercialization of advanced drugs, therapies, food supplements and administration routes based off of the cannabis plant. Cannabics' current flagship product is Cannabics SR an IP pending medical cannabis capsule designed specifically for cancer patients as a palliative care treatment. The company is preparing to launch its line of SR products in eligible states of the U.S and EU markets under existing medical cannabis regulatory pathways, while simultaneously preparing to launch a series of formal clinical studies in order to establish the unique medical benefits of its products for patients suffering from various indications.